FEDELI, WALTER ANTONIO
FEDELI, WALTER ANTONIO
Ki67 and PR in patients treated with CDK4/6 Inhibitors: A real-world experience
2020 Palleschi M.; Maltoni R.; Ravaioli S.; Vagheggini A.; Mannozzi F.; Fanini F.; Pirini F.; Tumedei M.M.; Barzotti E.; Cecconetto L.; Sarti S.; Manunta S.; Possanzini P.; Fedeli A.; Curcio A.; Altini M.; de Giorgi U.; Rocca A.; Bravaccini S.
Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer
2015 Rocca A.; Farolfi A.; Maltoni R.; Carretta E.; Melegari E.; Ferrario C.; Cecconetto L.; Sarti S.; Schirone A.; Fedeli A.; Andreis D.; Pietri E.; Ibrahim T.; Montalto E.; Amadori D.
Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy
2015 Rocca A.; Andreis D.; Fedeli A.; Maltoni R.; Sarti S.; Cecconetto L.; Pietri E.; Schirone A.; Bravaccini S.; Serra P.; Farolfi A.; Amadori D.
Trastuzumab-induced cardiotoxicity in early breast cancer patients: A retrospective study of possible risk and protective factors
2013 Farolfi A.; Melegari E.; Aquilina M.; Scarpi E.; Ibrahim T.; Maltoni R.; Sarti S.; Cecconetto L.; Pietri E.; Ferrario C.; Fedeli A.; Faedi M.; Nanni O.; Frassineti G.L.; Amadori D.; Rocca A.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Ki67 and PR in patients treated with CDK4/6 Inhibitors: A real-world experience | Palleschi M.; Maltoni R.; Ravaioli S.; Vagheggini A.; Mannozzi F.; Fanini F.; Pirini F.; Tumedei ...M.M.; Barzotti E.; Cecconetto L.; Sarti S.; Manunta S.; Possanzini P.; Fedeli A.; Curcio A.; Altini M.; de Giorgi U.; Rocca A.; Bravaccini S. | 2020-01-01 | DIAGNOSTICS | - | 1.01 Articolo in rivista | Ki67 and PR in Patients Treated with CDK4 6.pdf |
| Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer | Rocca A.; Farolfi A.; Maltoni R.; Carretta E.; Melegari E.; Ferrario C.; Cecconetto L.; Sarti S.;... Schirone A.; Fedeli A.; Andreis D.; Pietri E.; Ibrahim T.; Montalto E.; Amadori D. | 2015-01-01 | BREAST CANCER RESEARCH AND TREATMENT | - | 1.01 Articolo in rivista | - |
| Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy | Rocca A.; Andreis D.; Fedeli A.; Maltoni R.; Sarti S.; Cecconetto L.; Pietri E.; Schirone A.; Bra...vaccini S.; Serra P.; Farolfi A.; Amadori D. | 2015-01-01 | EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | - | 1.03 Recensione in rivista | - |
| Trastuzumab-induced cardiotoxicity in early breast cancer patients: A retrospective study of possible risk and protective factors | Farolfi A.; Melegari E.; Aquilina M.; Scarpi E.; Ibrahim T.; Maltoni R.; Sarti S.; Cecconetto L.;... Pietri E.; Ferrario C.; Fedeli A.; Faedi M.; Nanni O.; Frassineti G.L.; Amadori D.; Rocca A. | 2013-01-01 | HEART | - | 1.01 Articolo in rivista | - |